Occam Recruits CEO of Prominent Rare Disease Research Foundation
Founded in 1983, the Charcot-Marie-Tooth Association is a non-profit dedicated to finding a cure for CMT and improving the quality of life for those affected by this rare neurological disorder. Occam placed Suzanne “Sue” Bruhn, a biotech industry veteran, as the organization’s Chief Executive Officer in November 2023.
Sue brings over a decade of biotech CEO experience to CMTA and a strong commitment to rare disease drug development and patient advocacy dating back to her tenure at Shire. Suzanne has a Ph.D. in Chemistry from MIT and completed her post-doctoral work at Harvard Medical School. She currently sits on the boards of Pliant Therapeutics, Travere Therapeutics, Vigil Neuroscience, and MindMed.
Occam’s work with CMTA is part of the firm's executive search practice for life science-focused foundations and non-profit organizations. Having successfully partnered with esteemed non-profits such as Gavi, the Vaccine Alliance, and theBill & Melinda Gates Foundation in the past, we are gratified by the opportunity to continue to apply our efforts toward philanthropic endeavors.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.